RadPharm, Inc. and Medifacts International, Inc. have merged business operations to create CoreLab Partners; one of the largest independent core labs serving the worldwide drug development market today. The CoreLab Partners global footprint comprises more than 400 employees and includes offices with operational capabilities in North America, Europe and Asia. The company has supported over 100 sponsors on more than 450 clinical trials in 60 countries and boasts a 100% on-time delivery of all projects.
CoreLab Partners offers our sponsors a comprehensive suite of cost effective solutions across a broad range of imaging modalities, cardiac safety services and therapeutic indications.
RadPharm, Inc. and Medifacts International, Inc. have merged business operations to create CoreLab Partners; one of the largest independent core labs serving the worldwide drug development market today. The CoreLab Partners global footprint comprises more than 400 employees and includes offices with operational capabilities in North America, Europe and Asia. The company has supported over 100 sponsors on more than 450 clinical trials in 60 countries and boasts a 100% on-time delivery of all projects. 
